These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA. Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069 [TBL] [Abstract][Full Text] [Related]
3. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer. Qi L; Song Y; Chan THM; Yang H; Lin CH; Tay DJT; Hong H; Tang SJ; Tan KT; Huang XX; Lin JS; Ng VHE; Maury JJP; Tenen DG; Chen L Nucleic Acids Res; 2017 Oct; 45(18):10436-10451. PubMed ID: 28985428 [TBL] [Abstract][Full Text] [Related]
4. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer. Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780 [TBL] [Abstract][Full Text] [Related]
5. ADAR1 Transcriptome editing promotes breast cancer progression through the regulation of cell cycle and DNA damage response. Sagredo EA; Sagredo AI; Blanco A; Rojas De Santiago P; Rivas S; Assar R; Pérez P; Marcelain K; Armisén R Biochim Biophys Acta Mol Cell Res; 2020 Aug; 1867(8):118716. PubMed ID: 32275931 [TBL] [Abstract][Full Text] [Related]
6. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer. Nakano M; Fukami T; Gotoh S; Nakajima M J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287 [TBL] [Abstract][Full Text] [Related]
7. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response. Yang CC; Chen YT; Chang YF; Liu H; Kuo YP; Shih CT; Liao WC; Chen HW; Tsai WS; Tan BC Cell Death Dis; 2017 May; 8(5):e2833. PubMed ID: 28542129 [TBL] [Abstract][Full Text] [Related]
8. RNA Editing Enzyme ADAR1 Suppresses the Mobility of Cancer Cells via ARPIN. Park MJ; Jeong E; Lee EJ; Choi HJ; Moon BH; Kang K; Chang S Mol Cells; 2023 Jun; 46(6):351-359. PubMed ID: 36921992 [TBL] [Abstract][Full Text] [Related]
9. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence. Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943 [TBL] [Abstract][Full Text] [Related]
10. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis. de Santiago PR; Blanco A; Morales F; Marcelain K; Harismendy O; Sjöberg Herrera M; Armisén R Life Sci; 2021 Mar; 268():118956. PubMed ID: 33383047 [TBL] [Abstract][Full Text] [Related]
11. Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme ADAR1 are important prognostic biomarkers in gastric cancer. Okugawa Y; Toiyama Y; Shigeyasu K; Yamamoto A; Shigemori T; Yin C; Ichikawa T; Yasuda H; Fujikawa H; Yoshiyama S; Hiro J; Ohi M; Araki T; Kusunoki M; Goel A J Transl Med; 2018 Dec; 16(1):366. PubMed ID: 30563560 [TBL] [Abstract][Full Text] [Related]
12. RNA binding by ADAR3 inhibits adenosine-to-inosine editing and promotes expression of immune response protein MAVS. Raghava Kurup R; Oakes EK; Manning AC; Mukherjee P; Vadlamani P; Hundley HA J Biol Chem; 2022 Sep; 298(9):102267. PubMed ID: 35850307 [TBL] [Abstract][Full Text] [Related]
13. Marburg and Ebola Virus mRNA 3' Untranslated Regions Contain Negative Regulators of Translation That Are Modulated by ADAR1 Editing. Khadka S; Williams CG; Sweeney-Gibbons J; Basler CF J Virol; 2021 Sep; 95(19):e0065221. PubMed ID: 34346762 [TBL] [Abstract][Full Text] [Related]
14. ADAR1 Suppresses Interferon Signaling in Gastric Cancer Cells by MicroRNA-302a-Mediated IRF9/STAT1 Regulation. Jiang L; Park MJ; Cho CJ; Lee K; Jung MK; Pack CG; Myung SJ; Chang S Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867271 [TBL] [Abstract][Full Text] [Related]
15. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity. Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211 [TBL] [Abstract][Full Text] [Related]
16. Processing of Shiromoto Y; Sakurai M; Qu H; Kossenkov AV; Nishikura K RNA; 2020 Dec; 26(12):1801-1814. PubMed ID: 32817447 [TBL] [Abstract][Full Text] [Related]
17. Adenosine-to-inosine Alu RNA editing controls the stability of the pro-inflammatory long noncoding RNA NEAT1 in atherosclerotic cardiovascular disease. Vlachogiannis NI; Sachse M; Georgiopoulos G; Zormpas E; Bampatsias D; Delialis D; Bonini F; Galyfos G; Sigala F; Stamatelopoulos K; Gatsiou A; Stellos K J Mol Cell Cardiol; 2021 Nov; 160():111-120. PubMed ID: 34302813 [TBL] [Abstract][Full Text] [Related]
18. Global Transcriptome Analysis of RNA Abundance Regulation by ADAR in Lung Adenocarcinoma. Sharpnack MF; Chen B; Aran D; Kosti I; Sharpnack DD; Carbone DP; Mallick P; Huang K EBioMedicine; 2018 Jan; 27():167-175. PubMed ID: 29273356 [TBL] [Abstract][Full Text] [Related]